<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Others &#8211; Polypharma: Generics Developer</title>
	<atom:link href="https://polypharma.de/en/category/others/feed/" rel="self" type="application/rss+xml" />
	<link>https://polypharma.de</link>
	<description>Full-service in the production of generics and delivery of raw materials in Africa and the Middle East</description>
	<lastBuildDate>Tue, 28 Sep 2021 09:11:17 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://polypharma.de/wp-content/uploads/2020/07/cropped-Polypharma-Technologies-and-Sciences-Hamburg-150x150.png</url>
	<title>Others &#8211; Polypharma: Generics Developer</title>
	<link>https://polypharma.de</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Website relaunch</title>
		<link>https://polypharma.de/en/2020/12/website-relaunch/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Sat, 05 Dec 2020 18:20:39 +0000</pubDate>
				<category><![CDATA[Others]]></category>
		<category><![CDATA[Polypharma]]></category>
		<category><![CDATA[Polypharma tech]]></category>
		<category><![CDATA[Polypharma Technologies & Sciences GmbH]]></category>
		<category><![CDATA[website relaunch]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=7186</guid>

					<description><![CDATA[Our new website is online. Chlick for more: www.polypharma.de/en]]></description>
		
		
		
			</item>
		<item>
		<title>Ensuring pharmaceutical production even during the COVID-19 crisis</title>
		<link>https://polypharma.de/en/2020/03/ensuring-pharmaceutical-production-even-during-the-covid-19-crisis/</link>
		
		<dc:creator><![CDATA[Liza Knezlova]]></dc:creator>
		<pubDate>Wed, 04 Mar 2020 10:48:15 +0000</pubDate>
				<category><![CDATA[Others]]></category>
		<guid isPermaLink="false">https://polypharma.de/?p=6542</guid>

					<description><![CDATA[Every organisation should prepare its response to incidents based on their business impact, to allocate valuable resources to what poses the greatest threat to ongoing operations. A business stability guideline prepares an organisation to continue operations amidst the myriad of potential business disruptions and aims to achieve a high level of resilience across all departments [&#8230;]]]></description>
		
		
		
			</item>
	</channel>
</rss>
